Allogeneic Virus-specific T Cell Lines (VSTs)
Clinical trial NCT02510417 · COMPLETED
Trial details
- NCT number
- NCT02510417
- Sponsor
- Catherine Bollard
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2017-09-11
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.